-
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
-
View Affiliations Hide AffiliationsOliver Donoso Mantkeoliverdonoso qcmd.org
-
View Citation Hide Citation
Citation style for this article: . International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020. Euro Surveill. 2020;25(27):pii=2001223. https://doi.org/10.2807/1560-7917.ES.2020.25.27.2001223 Received: 17 Jun 2020; Accepted: 30 Jun 2020
- Previous Article
- Table of Contents
- Next Article
Abstract
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
Full text loading...